Ontology highlight
ABSTRACT: Background
Ankylosing spondylitis (AS) is a chronic inflammatory disease with worldwide high prevalence. Although AS is strongly associated with HLA-B27 MHC-I antigen presentation, the role played by αβ T cells in AS remains elusive.Methods
Utilizing TCRβ repertoire sequencing and bioinformatics tools developed in house, we analyzed overall TCR repertoire structures and antigen-recognizing CDR3 motifs in AS patients with different disease activities.Findings
We found that disease progression is associated with both CD4+ and CD8+ T cell oligo-clonal expansion, which suggests that αβ T cell activation may mediate AS disease progression. By developing a bioinformatics platform to dissect antigen-specific responses, we discovered a cell population consisting of both CD4+ and CD8+ T cells expressing identical TCRs, herein termed CD4/8 T cells. CD4/8 clonotypes were highly enriched in the spondyloarthritic joint fluid of patients, and their expansion correlated with the activity of disease.Interpretation
These results provide evidence on the T cell clone side to reveal the potential role of CD4/8 T cells in the etiology of AS development.
SUBMITTER: Zheng M
PROVIDER: S-EPMC6796593 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
Zheng Ming M Zhang Xin X Zhou Yinghui Y Tang Juan J Han Qing Q Zhang Yang Y Ni Qingshan Q Chen Gang G Jia Qingzhu Q Yu Haili H Liu Siqi S Robins Elizabeth E Jiang Ning Jenny NJ Wan Ying Y Li Qi-Jing QJ Chen Zhi-Nan ZN Zhu Ping P
EBioMedicine 20190830
<h4>Background</h4>Ankylosing spondylitis (AS) is a chronic inflammatory disease with worldwide high prevalence. Although AS is strongly associated with HLA-B27 MHC-I antigen presentation, the role played by αβ T cells in AS remains elusive.<h4>Methods</h4>Utilizing TCRβ repertoire sequencing and bioinformatics tools developed in house, we analyzed overall TCR repertoire structures and antigen-recognizing CDR3 motifs in AS patients with different disease activities.<h4>Findings</h4>We found that ...[more]